Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Oncogene|November 15, 1997
Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimersA Carpentier, N Balitrand, C Rochette-Egly, et al.
FEBS Letters|October 30, 2001
The novel co-activator CRABPII binds to RARalpha and RXRalpha via two nuclear receptor interacting domains and does not require the AF-2 'core'J N Bastie, G Despouy, N Balitrand, et al.
Leukemia|January 1, 1994
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemiaM Cornic, L Delva, S Castaigne, et al.
Leukemia|January 1, 1995
Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacyA Agadir, M Cornic, P Lefebvre, et al.
Leukemia|June 1, 1994
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemiaM Cornic, L Delva, S Castaigne, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1987
Differential expression of c-myc and c-fos oncogenes during the differentiation of human leukemic cells by Ara-CC Chomienne, R Emanoil-Ravier, N Balitrand, et al.
Anticancer Research|July 1, 1986
Granulocytic differentiation induced by retinoic acid in HL-60 cells is associated with changes in adenylate cyclase activityG Thomas, C Chomienne, N Balitrand, et al.
Leukemia|December 1, 1995
In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cellsC Calabresse, S Barbey, L Venturini, et al.
Scandinavian Journal of Haematology|March 1, 1981
Granulocyte progenitor compartments after allogeneic bone marrow graftsA Faille, D Maraninchi, E Gluckman, et al.
In Vivo (Athens, Greece)|May 1, 1988
Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugsC Chomienne, A Chedeville, N Balitrand, et al.
Pageof 5